Development of caseous calcification of mitral annulus after initiation of hemodialysis therapy

Hiroki Usuku1,2, Eiichiro Yamamoto2, Fumi Oike2

  • 1Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.

Insights

Caseous calcification of mitral annulus (CCMA) is linked to end-stage renal disease. This case highlights CCMA development after switching to hemodialysis, emphasizing echocardiography

Area of Science:

  • Cardiology
  • Nephrology
  • Pathology

Background:

  • End-stage renal disease (ESRD) often necessitates renal replacement therapy, including peritoneal dialysis (PD) and hemodialysis (HD).
  • Mitral annular calcification is a known complication in patients with chronic kidney disease.
  • Caseous calcification of mitral annulus (CCMA) is a rare form of mitral annular calcification.

Observation:

  • A 59-year-old man with a history of 7 years of PD followed by 6 years of HD presented with a growing mass on the posterior mitral leaflet.
  • Transthoracic echocardiography revealed a 15 mm echoic mass, which enlarged to over 25 mm within 6 years of commencing HD.
  • Surgical intervention included tumor resection and mitral valve replacement.

Findings:

  • Histological examination of the resected mass showed multiple calcified nodules and granulation tissue.
  • The mass exuded a white, opalescent liquid upon incision.
  • The findings confirmed the diagnosis of caseous calcification of the mitral annulus (CCMA).

Implications:

  • This case suggests that CCMA can develop or progress significantly after the initiation of hemodialysis in patients with ESRD.
  • Routine echocardiography is crucial for the early detection of CCMA, particularly in patients transitioning between PD and HD.
  • Understanding the progression of CCMA in ESRD patients is vital for timely intervention and management.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.5K
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Initiation of Translation02:33

Initiation of Translation

8.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
718
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
790
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
527